MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
579
Beneficiaries
—
Total drug cost
$119K
Distinct drugs
24
Brand share
34.7%
Top prescribed drugs
Apixaban76 claims
Rivaroxaban60 claims
Ondansetron Hcl54 claims
Prochlorperazine Maleate49 claims
Gabapentin35 claims
QUALITY · MIPS · 2024
Final MIPS score
91.8
Quality
91.9
Cost
71.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.71%
Subgroup
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$2K
Payment records
109
By payment type
Food and Beverage$2K
Top paying entities
Food and Beverage$2K
REFERRAL NETWORK
Where Robin Erwin's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 118 | 196 |
| Brooke Uptagrafft Family Practice · Huntsville, AL | 67 | 143 |
| THE HEALTH CARE AUTHORITY OF THE CITY OF HUNTSVILLE | 43 | 94 |
| CRESTWOOD HEALTHCARE LP | 17 | 29 |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | 13 | 18 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE